TOKYO, JAPAN- May 28, 2007- NOF CORP attends 2007 AAPS National Biotechnology Conference in San Diego, CA held on June 24th to 27th.

NOF presents new DDS technology and products for any biologics delivery.
1. Phospholipids for inhalation delivery
Our high purity, unique synthetic phospholipids have been used for inhalation delivery for many biologics.

2. Novel Vaccine Formulation
IgE-prevent Vaccine formulation will be introduced with new research data.

3. 60kDa, 80kDa Activated PEGs
Larger size PEGylation is much efficient for getting the drug circulation longer in Vivo for any biologics.

4. PEG-Drug development support
Small scale PEG-Drug sample manufacturing is starting for customer support with NOF PEG experience and expertise.

NOF presenters are looking forward to seeing you at Booth 621 in 2007 AAPS BIO in San Diego, CA.

NOF CORPORATION
DDS Customer Service
E-mail:ddsinfo@nof.co.jp

About DDS Development Department
As an intergrated chemical manufacture, NOF CORPORATION, featuring diverse activities from "Biosphere to Outer Space" DDS Development Department has now focused on the development of innovative drug modifiers, carriers and solubilizers such as PEG, phospholipids, highly purified oleic acid nonionic surfactants and other novel excipients for pharmaceutical use. As the worldwide leader in drug delivery systems (DDS), NOF DDS provides excellent product quality for the pharmaceutical industries.